Cost-effectiveness of pioglitazone in patients with type 2 diabetes and a history of macrovascular disease in a Swiss setting
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SMW supporting association (Trägerverein Swiss Medical Weekly SMW)
2009-03-01
|
| Series: | Swiss Medical Weekly |
| Subjects: | |
| Online Access: | https://www.smw.ch/index.php/smw/article/view/956 |
| _version_ | 1811288415413469184 |
|---|---|
| author | KM Erny-Albrecht E Erdmann |
| author_facet | KM Erny-Albrecht E Erdmann |
| author_sort | KM Erny-Albrecht |
| collection | DOAJ |
| first_indexed | 2024-04-13T03:36:43Z |
| format | Article |
| id | doaj.art-404706b38eed462195127e15c8820313 |
| institution | Directory Open Access Journal |
| issn | 1424-3997 |
| language | English |
| last_indexed | 2024-04-13T03:36:43Z |
| publishDate | 2009-03-01 |
| publisher | SMW supporting association (Trägerverein Swiss Medical Weekly SMW) |
| record_format | Article |
| series | Swiss Medical Weekly |
| spelling | doaj.art-404706b38eed462195127e15c88203132022-12-22T03:04:19ZengSMW supporting association (Trägerverein Swiss Medical Weekly SMW)Swiss Medical Weekly1424-39972009-03-01139111210.4414/smw.2009.12381Cost-effectiveness of pioglitazone in patients with type 2 diabetes and a history of macrovascular disease in a Swiss settingKM Erny-AlbrechtE Erdmannhttps://www.smw.ch/index.php/smw/article/view/956Macrovascular eventsCosteffectivenessSwitzerlandPRO activePioglitazonetype 2 diabetes mellitus |
| spellingShingle | KM Erny-Albrecht E Erdmann Cost-effectiveness of pioglitazone in patients with type 2 diabetes and a history of macrovascular disease in a Swiss setting Swiss Medical Weekly Macrovascular events Costeffectiveness Switzerland PRO active Pioglitazone type 2 diabetes mellitus |
| title | Cost-effectiveness of pioglitazone in patients with type 2 diabetes and a history of macrovascular disease in a Swiss setting |
| title_full | Cost-effectiveness of pioglitazone in patients with type 2 diabetes and a history of macrovascular disease in a Swiss setting |
| title_fullStr | Cost-effectiveness of pioglitazone in patients with type 2 diabetes and a history of macrovascular disease in a Swiss setting |
| title_full_unstemmed | Cost-effectiveness of pioglitazone in patients with type 2 diabetes and a history of macrovascular disease in a Swiss setting |
| title_short | Cost-effectiveness of pioglitazone in patients with type 2 diabetes and a history of macrovascular disease in a Swiss setting |
| title_sort | cost effectiveness of pioglitazone in patients with type 2 diabetes and a history of macrovascular disease in a swiss setting |
| topic | Macrovascular events Costeffectiveness Switzerland PRO active Pioglitazone type 2 diabetes mellitus |
| url | https://www.smw.ch/index.php/smw/article/view/956 |
| work_keys_str_mv | AT kmernyalbrecht costeffectivenessofpioglitazoneinpatientswithtype2diabetesandahistoryofmacrovasculardiseaseinaswisssetting AT eerdmann costeffectivenessofpioglitazoneinpatientswithtype2diabetesandahistoryofmacrovasculardiseaseinaswisssetting |